interventions: in the estrogen-alone trial, 1 daily tablet containing either 0.625 mg/d of cee vs matching placebo; in the estrogen plus progestin trial, 1 daily tablet containing cee (0.625 mg/d) plus mpa (2.5 mg/d) vs matching placebos.